Therapy Cessation
19 drugs8,756 FAERS reportsMedDRA PT
GET
/api/v1/reaction/therapy-cessationReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Therapy Cessation (19)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Lomitapide79221%
- 2Deuruxolitinib815%
- 3Pexidartinib8112%
- 4Mecamylamine110%
- 5Metreleptin927.5%
- 6Dalfampridine4,5106.3%
- 7Clascoterone866.1%
- 8Retifanlimab25.4%
- 9Voxelotor1,0404.7%
- 10Sonidegib684.6%
- 11Brodalumab874.5%
- 12Abiraterone1,5593.9%
- 13Zuranolone433.2%
- 14Tildrakizumab543.1%
- 15Interferon Gamma-1b342.5%
- 16Seladelpar42.0%
- 17Ponesimod51.6%
- 18Glecaprevir1451.3%
- 19Pibrentasvir1451.3%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Therapy Interrupted7 shared · 0.12
- Muscle Twitching2 shared · 0.09
- Drug Dose Omission5 shared · 0.08
- Product Use Complaint2 shared · 0.07
- Disease Recurrence2 shared · 0.06
- Blood Cholesterol Increased2 shared · 0.06
- Multiple Sclerosis2 shared · 0.06
- Multiple Sclerosis Relapse2 shared · 0.05
- Blood Creatine Phosphokinase Increased2 shared · 0.04
- Therapy Non-responder2 shared · 0.04
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.